Literature DB >> 31582557

Safety of using direct oral anticoagulants in the diagnostic workup of outpatients with suspicion of acute venous thromboembolism.

Maddie S Stephen1, Lana Castellucci1, Marc Carrier1, Lisa Duffett1, Gregoire Le Gal1, Marc Rodger1, Philip S Wells1, Aurélien Delluc2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31582557      PMCID： PMC7271588          DOI： 10.3324/haematol.2019.232884

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  6 in total

1.  Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH.

Authors:  S Kaatz; D Ahmad; A C Spyropoulos; S Schulman
Journal:  J Thromb Haemost       Date:  2015-11       Impact factor: 5.824

2.  Management of primary care patients with suspected deep vein thrombosis: use of a therapeutic dose of low-molecular-weight heparin to avoid urgent ultrasonographic evaluation.

Authors:  D Imberti; W Ageno; F Dentali; M Giorgi Pierfranceschi; E Croci; D Garcia
Journal:  J Thromb Haemost       Date:  2006-05       Impact factor: 5.824

3.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Clive Kearon; Elie A Akl; Anthony J Comerota; Paolo Prandoni; Henri Bounameaux; Samuel Z Goldhaber; Michael E Nelson; Philip S Wells; Michael K Gould; Francesco Dentali; Mark Crowther; Susan R Kahn
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

4.  Deferment of objective assessment of deep vein thrombosis and pulmonary embolism without increased risk of thrombosis: a practical approach based on the pretest clinical model, D-dimer testing, and the use of low-molecular-weight heparins.

Authors:  Sergio Siragusa; Raffaela Anastasio; Camillo Porta; Francesco Falaschi; Stefano Pirrelli; Piernicola Palmieri; Gabriella Gamba; Katerina Granzow; Alessandra Malato; Viviana Minardi; Paola Tatoni; Maria Antonietta Bressan; Guglielmo Mariani
Journal:  Arch Intern Med       Date:  2004 Dec 13-27

5.  Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients.

Authors:  S Schulman; C Kearon
Journal:  J Thromb Haemost       Date:  2005-04       Impact factor: 5.824

Review 6.  Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH.

Authors:  K Martin; J Beyer-Westendorf; B L Davidson; M V Huisman; P M Sandset; S Moll
Journal:  J Thromb Haemost       Date:  2016-04-27       Impact factor: 5.824
  6 in total
  1 in total

1.  Safety and feasibility of rivaroxaban in deferred workup of patients with suspected deep vein thrombosis.

Authors:  Synne G Fronas; Anders E A Dahm; Hilde S Wik; Camilla T Jørgensen; Jostein Gleditsch; Nezar Raouf; René Holst; Frederikus A Klok; Waleed Ghanima
Journal:  Blood Adv       Date:  2020-06-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.